Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 4.

Journal Article

Jockel-Schneider, Yvonne, Schlagenhauf, Ulrich, Petsos, Hari, Ruettermann, Stefan, Schmidt, Jana, Ziebolz, Dirk, Wehner, Christian, Laky, Markus, Rott, Thea, Noack, Michael, Noack, Barbara and Lorenz, Katrin (2021). Impact of 0.1% octenidine mouthwash on plaque re-growth in healthy adults: a multi-center phase 3 randomized clinical trial. Clin. Oral Investig., 25 (7). S. 4681 - 4690. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1436-3771

Lang, Gabriele E., Stahl, Andreas, Voegeler, Jessica, Quiering, Claudia, Lorenz, Katrin, Spital, Georg and Liakopoulos, Sandra (2020). Efficacy and safety of ranibizumab with or without panretinal laser photocoagulation versus laser photocoagulation alone in proliferative diabetic retinopathy - the PRIDE study. Acta Ophthalmol., 98 (5). S. E530 - 10. HOBOKEN: WILEY. ISSN 1755-3768

Lang, Gabriele E., Stahl, Andreas ORCID: 0000-0002-8013-7597, Voegeler, Jessica, Quiering, Claudia, Zaremba, Laureen, Lorenz, Katrin, Spital, Georg and Liakopoulos, Sandra (2022). Observational outcomes in proliferative diabetic retinopathy patients following treatment with ranibizumab, panretinal laser photocoagulation or combination therapy - The non-interventional second year follow-up to the PRIDE study. Acta Ophthalmol., 100 (2). S. E578 - 10. HOBOKEN: WILEY. ISSN 1755-3768

Lorenz, Katrin, Scheller, Yvonne, Bell, Katharina, Grus, Franz, Ponto, Katharina A., Bock, Felix, Cursiefen, Claus, Flach, Jens, Gehring, Marta, Peto, Tunde ORCID: 0000-0001-6265-0381, Silva, Rufino, Tal, Yossi and Pfeiffer, Norbert (2017). A prospective, randomised, placebocontrolled, double- masked, three-armed, multicentre phase II/ III trial for the Study of a Topical Treatment of Ischaemic Central Retinal Vein Occlusion to Prevent Neovascular Glaucoma-the STRONG study: study protocol for a randomised controlled trial. Trials, 18. LONDON: BMC. ISSN 1745-6215

This list was generated on Fri Apr 19 08:30:56 2024 CEST.